305 filings
8-K
PSTV
Plus Therapeutics Inc
14 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
PSTV
Plus Therapeutics Inc
13 Mar 24
Regulation FD Disclosure
8:01am
8-K
PSTV
Plus Therapeutics Inc
5 Mar 24
Plus Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
4:04pm
8-K
PSTV
Plus Therapeutics Inc
20 Nov 23
Regulation FD Disclosure
7:01am
8-K
PSTV
Plus Therapeutics Inc
31 Oct 23
Other Events
4:55pm
8-K
x08az2iwgtnomqa hu
31 Oct 23
Plus Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights
4:06pm
8-K
c5amscggna exaq8ue
14 Aug 23
Plus Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights
4:12pm
8-K
oncijzsy5r92
16 May 23
Other Events
8:09am
8-K
8uek cy8psbh
28 Apr 23
Plus Therapeutics Announces Reverse Stock Split
4:34pm
8-K
8ljz9
21 Apr 23
Submission of Matters to a Vote of Security Holders
6:30am
8-K
s1syvcy0 a8tbock2
20 Apr 23
Plus Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights
4:04pm
8-K
a31oqhni7s5dbe38i
13 Mar 23
Regulation FD Disclosure
6:30am
8-K
013uycv9b8hae
3 Mar 23
Entry into a Material Definitive Agreement
4:31pm
8-K
lglzqkunfry1nmq0iw
23 Feb 23
Plus Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
4:10pm
8-K
0oc3u
15 Dec 22
Other Events
4:28pm
8-K
f9r246
28 Nov 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:16pm
8-K
u0gf juruhoq2hgefmso
20 Oct 22
Plus Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
4:33pm
8-K
4khr4vayw
22 Sep 22
Plus Therapeutics Executes $17.6 Million Award Contract with Cancer
7:02am
8-K
06oy eykrv3bbjz7
9 Sep 22
Entry into a Material Definitive Agreement
4:43pm
8-K
lh5ops 6o76
17 Aug 22
Other Events
5:27pm